10.1016/j.str.2010.01.020 420 MiuraT.ThomasG
Username or email Reset password
The Ultimate Guide to Beauty IV Therapy: Benefits & What to Expect Explore beauty IV therapy benefits for skin, hair, and nails
In late 2023, the FDA added more than a dozen peptides including both BPC-157 and thymosin alpha 1 to its list of substances that should not be compounded because the agency has identified potential significant safety risks. For BPC-157, the agency warned that the peptide could trigger an immune response
Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for chinese patients with hormone receptor-positive advanced breast cancer: a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial
This is not optional background information